Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
Recruiting · NCT07693426 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-07-30 | NCT07693426 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 5 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Chaoyang Hospital, Capital Medical University | Beijing | China | 5 |
| Qilu Hospital, Shandong University | Jinan | China | 1 |
| Qilu Second Hospital, Shandong University | Jinan | China | 1 |
| Shengjing Hospital, China Medical University | Shenyang | China | 2 |
| Wuhan Central Hospital | Wuhan | China | 10 |